MR-linac

DEVICE4 trials

Sponsors

Cancer Institute and Hospital, Chinese Academy of Medical Sciences, M.D. Anderson Cancer Center, Sichuan Cancer Hospital and Research Institute, The Second Affiliated Hospital of Hainan Medical University

Conditions

Adaptive RadiotherapyLocalised DiseaseMagnetic Resonance-linacOligometastatic DiseaseOncologyOverall Response RateProstate CancerQuality of Life

Phase 2

Phase II Cohort of Spinal Stereotactic Radiotherapy in Patients Using a MR LINAC

RecruitingNCT05709782

M.D. Anderson Cancer CenterSpinal Disease

Start: 2023-05-09End: 2029-01-13Target: 40Updated: 2026-07-21

Unknown Phase

MR-linac Guided Ultra-hypofractionated RT for Prostate Cancer (SMART-P01 and SMART-P02)

RecruitingNCT05183074

Cancer Institute and Hospital, Chinese Academy of Medical SciencesAdaptive Radiotherapy, Localised Disease, Magnetic Resonance-linac +4

Start: 2021-02-01End: 2027-12-31Target: 50Updated: 2025-12-11

Study on the Safety and Efficacy of MR-Linac Technique in Patients With Unresectable Locally Advanced Colon Cancer

RecruitingNCT06244537

Sichuan Cancer Hospital and Research InstituteSafety and Efficacy

Start: 2024-04-01End: 2027-12-31Target: 20Updated: 2025-09-09

Precision Radiotherapy for Tumours Using Magnetic Resonance-guided Linear Accelerator (MR-Linac)

RecruitingNCT06531681

The Second Affiliated Hospital of Hainan Medical UniversityOncology, Overall Response Rate, Quality of Life +1

Start: 2023-08-19End: 2028-12-31Target: 3000Updated: 2025-02-13

Related Papers

Quantifying intrafractional colon tumor motion on 1.5 T MR-linac cine-MRI and applying anisotropic residual-motion margins for SBRT.

2026-04-16